INVO Bioscience, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Bioscience, Inc. (Nevada) on April 7, 2017, covering events occurring on April 5, 2017. The filing addresses significant changes in corporate governance and the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
- Director Resignation: Claude Ranoux resigned effective immediately as a member of the Board of Directors on April 5, 2017.
- Reason for Departure: Dr. Ranoux cited "recent events with respect to the operation of the Board of Directors" limiting his ability to serve effectively. The Board attributed the resignation to prior disagreements regarding the removal of Dr. Ranoux from officer positions (President, Treasurer, Chief Scientist) in September 2016 and the subsequent election of Kathleen Karloff and Robert Bowdring to those roles.
- Historical Context: Since September 2016, Dr. Ranoux had voted against virtually all Board actions approved by Ms. Karloff and Mr. Bowdring and had expressed a desire to replace current management.
Outlook, Risks, and Management Commentary
The Board of Directors accepted Dr. Ranoux's resignation during a special telephonic meeting on April 5, 2017. The Board intends to review a list of potential candidates to fill the vacancy. The company expressed gratitude for Dr. Ranoux's past efforts. No specific financial guidance or new risk factors were disclosed in this filing.
Key Facts for Investor Verification
- Verify the current composition of the Board of Directors following the resignation of Claude Ranoux.
- Confirm the timeline and status of the search for a replacement director.
- Review prior filings (specifically from September 2016) to understand the full context of the management restructuring that precipitated this resignation.
- Check for any subsequent filings regarding the appointment of a new director or further governance disputes.